More Inoviq Ltd news
Inoviq LtdASX: IIQ

Israeli Patent Issued in Bard1 Core Patent Family

Mar 20, 2018 at 10:46 PM EDT · Issued by Inoviq Ltd

Filed with ASX · Mar 20, 2018 at 10:46 PM EDT · 2 pages · English

On 6ix: 6ix.com/news/israeli-patent-issued-in-bard1-core-patent-family

Inoviq Ltd on 6ix

Story so far

  • Australian Patent IssuedAug 7, 2017

Earlier from Inoviq

  • Additional BARD1 Ovarian Test ResultsMar 5, 2018
  • Grant of Japanese PatentFeb 1, 2018
  • Results of BARD1 ovarian cancer studyJan 9, 2018
  • Research and Development UpdateOct 4, 2017
  • Appendix 4E Preliminary Financial ResultsAug 31, 2017

Later from Inoviq

  • Capital RaisingMar 21, 2018
  • Voluntary SuspensionMay 14, 2018
  • Contract Development Agreement SignedMay 18, 2018
  • Improved Performance of BARD1 Ovarian TestJun 19, 2018
  • US Patent Issued Protecting BARD1 Ovarian TestJul 11, 2018
All Inoviq news releases↗

Follow Inoviq into a list and get an email when it puts out news.

Follow Inoviq
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer